Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Shuch

Showing results (41-50 of 176) with videos related to

Pageof 18
Sort By:
A&A Practice|January 29, 2021
Telemedicine-Based Perioperative Management of Pheochromocytoma in a Patient With Von Hippel Lindau Disease: A Case ReportDane Saksa, Brian Shuch, Timothy Donahue, et al.
Urologic Oncology|September 9, 2008
Surveillance for renal cell carcinoma: why and how? When and how often?Tobias Klatte, John S Lam, Brian Shuch, et al.
Scientific Reports|August 4, 2019
Quantitative Profiling of Oncometabolites in Frozen and Formalin-Fixed Paraffin-Embedded Tissue Specimens by Liquid Chromatography Coupled with Tandem Mass SpectrometryXun Bao, Jianmei Wu, Brian Shuch, et al.
Cancer|May 16, 2020
Estimation of the carrier frequency of fumarate hydratase alterations and implications for kidney cancer risk in hereditary leiomyomatosis and renal cancerBrian Shuch, Shantao Li, Harvey Risch, et al.
Urology|May 25, 2024
Utilization of a Third-party Partnership in Tele-genetic Risk Assessment Program in Genitourinary OncologyLin Lin, Eric Lu, Josh Yurasits, et al.
Cancer|December 19, 2018
Risk factors for metachronous bilateral renal cell carcinoma: A surveillance, epidemiology, and end results analysisJamil S Syed, Kevin A Nguyen, Theodore R Holford, et al.
Urologic Oncology|April 2, 2017
End-stage renal disease secondary to renal malignancy: Epidemiologic trends and survival outcomesKevin A Nguyen, Srinivas Vourganti, Jamil S Syed, et al.
Journal of Cancer|April 7, 2012
Targeting the mTOR pathway in Chromophobe Kidney CancerBrian Shuch, Srinivas Vourganti, Julia C Friend, et al.
Journal of Cancer|May 17, 2013
Low Grade Micropapillary Urothelial Carcinoma, Does It Exist? - Analysis of Management and Outcomes from the Surveillance, Epidemiology and End Results (SEER) DatabaseSrinivas Vourganti, Andrew Harbin, Eric A Singer, et al.
Biomed Research International|October 9, 2015
MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway InhibitorsBrian Shuch, Ryan Falbo, Fabio Parisi, et al.
Pageof 18

Showing results (41-50 of 176) with videos related to

Sort By:
Pageof 18
A&A Practice|January 29, 2021
Telemedicine-Based Perioperative Management of Pheochromocytoma in a Patient With Von Hippel Lindau Disease: A Case ReportDane Saksa, Brian Shuch, Timothy Donahue, et al.
Urologic Oncology|September 9, 2008
Surveillance for renal cell carcinoma: why and how? When and how often?Tobias Klatte, John S Lam, Brian Shuch, et al.
Scientific Reports|August 4, 2019
Quantitative Profiling of Oncometabolites in Frozen and Formalin-Fixed Paraffin-Embedded Tissue Specimens by Liquid Chromatography Coupled with Tandem Mass SpectrometryXun Bao, Jianmei Wu, Brian Shuch, et al.
Cancer|May 16, 2020
Estimation of the carrier frequency of fumarate hydratase alterations and implications for kidney cancer risk in hereditary leiomyomatosis and renal cancerBrian Shuch, Shantao Li, Harvey Risch, et al.
Urology|May 25, 2024
Utilization of a Third-party Partnership in Tele-genetic Risk Assessment Program in Genitourinary OncologyLin Lin, Eric Lu, Josh Yurasits, et al.
Cancer|December 19, 2018
Risk factors for metachronous bilateral renal cell carcinoma: A surveillance, epidemiology, and end results analysisJamil S Syed, Kevin A Nguyen, Theodore R Holford, et al.
Urologic Oncology|April 2, 2017
End-stage renal disease secondary to renal malignancy: Epidemiologic trends and survival outcomesKevin A Nguyen, Srinivas Vourganti, Jamil S Syed, et al.
Journal of Cancer|April 7, 2012
Targeting the mTOR pathway in Chromophobe Kidney CancerBrian Shuch, Srinivas Vourganti, Julia C Friend, et al.
Journal of Cancer|May 17, 2013
Low Grade Micropapillary Urothelial Carcinoma, Does It Exist? - Analysis of Management and Outcomes from the Surveillance, Epidemiology and End Results (SEER) DatabaseSrinivas Vourganti, Andrew Harbin, Eric A Singer, et al.
Biomed Research International|October 9, 2015
MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway InhibitorsBrian Shuch, Ryan Falbo, Fabio Parisi, et al.
Pageof 18